Lung cancer immunotherapy drug to be available on the NHS
NHS England has agreed with pharmaceutical company MSD to make the lung cancer drug pembrolizumab available for routine use on the NHS.
New trial results show pembrolizumab extends life for certain adults with lung cancer for more than a year. More....
